Add to ORKGThe use of stereotactic ablative radiotherapy (SABR) in the UK has expanded over the past decade, in part as the result of several UK clinical trials and a recent NHS England Commissioning through Evaluation programme. A UK SABR Consortium consensus for normal tissue constraints for SABR was published in 2017, based on the existing literature at the time. The published literature regarding SABR has increased in volume over the past 5 years and multiple UK centres are currently working to develop new SABR services. A review and update of the previous consensus is therefore appropriate and timely. It is hoped that this document will provide a useful resource to facilitate safe and consistent SABR practice
OBJECTIVE: Stereotactic ablative radiotherapy (SABR) has become the standard of care for suitable pa...
INTRODUCTION Stereotactic Ablative Radiotherapy (SABR) is increasingly used to treat metastatic o...
INTRODUCTION: Stereotactic ablative radiotherapy (SABR) for lung cancer is a modality of treatment t...
The use of stereotactic ablative radiotherapy (SABR) in the UK has expanded over the past decade, in...
The use of stereotactic ablative radiotherapy (SABR) in the UK has expanded over the past decade, in...
Six UK studies investigating stereotactic ablative radiotherapy (SABR) are currently open. Many of t...
Six UK studies investigating stereotactic ablative radiotherapy (SABR) are currently open. Many of t...
Stereotactic ablative radiotherapy (SABR) has taken a pivotal role in early lung cancer management p...
Stereotactic Ablative Radiotherapy (SABR) is increasingly used to treat metastatic oligorecurrence a...
Stereotactic Ablative Body Radiotherapy (SABR) is an extension of the concepts of Stereotactic Radio...
Background and purpose: Radiotherapy utilisation rates considerably vary across different countries ...
Aim: Oligometastatic cancer is being increasingly managed with aggressive local therapy using stereo...
Stereotactic ablative radiotherapy (SABR) is an addition to the armamentarium against cancer. The te...
Stereotactic ablative radiotherapy (SABR) is a well-established treatment for patients with medicall...
Abstract Background Oligometastases refer to a state of disease where cancer has spread beyond the p...
OBJECTIVE: Stereotactic ablative radiotherapy (SABR) has become the standard of care for suitable pa...
INTRODUCTION Stereotactic Ablative Radiotherapy (SABR) is increasingly used to treat metastatic o...
INTRODUCTION: Stereotactic ablative radiotherapy (SABR) for lung cancer is a modality of treatment t...
The use of stereotactic ablative radiotherapy (SABR) in the UK has expanded over the past decade, in...
The use of stereotactic ablative radiotherapy (SABR) in the UK has expanded over the past decade, in...
Six UK studies investigating stereotactic ablative radiotherapy (SABR) are currently open. Many of t...
Six UK studies investigating stereotactic ablative radiotherapy (SABR) are currently open. Many of t...
Stereotactic ablative radiotherapy (SABR) has taken a pivotal role in early lung cancer management p...
Stereotactic Ablative Radiotherapy (SABR) is increasingly used to treat metastatic oligorecurrence a...
Stereotactic Ablative Body Radiotherapy (SABR) is an extension of the concepts of Stereotactic Radio...
Background and purpose: Radiotherapy utilisation rates considerably vary across different countries ...
Aim: Oligometastatic cancer is being increasingly managed with aggressive local therapy using stereo...
Stereotactic ablative radiotherapy (SABR) is an addition to the armamentarium against cancer. The te...
Stereotactic ablative radiotherapy (SABR) is a well-established treatment for patients with medicall...
Abstract Background Oligometastases refer to a state of disease where cancer has spread beyond the p...
OBJECTIVE: Stereotactic ablative radiotherapy (SABR) has become the standard of care for suitable pa...
INTRODUCTION Stereotactic Ablative Radiotherapy (SABR) is increasingly used to treat metastatic o...
INTRODUCTION: Stereotactic ablative radiotherapy (SABR) for lung cancer is a modality of treatment t...